DNA Vaccine Shows Promising, Long-Term Results Against Ebola Virus
October 10, 2018
(UPI) – A synthetic DNA vaccine is showing immediate and long-term promising results against the Ebola virus in preclinical animal research. Scientists at The Wistar Institute Vaccine and Immunotherapy Centers designed optimized synthetic DNA vaccine candidates that target a virus surface protein called glycoprotein. The findings were published Wednesday in the Journal of Infectious Diseases.